CSM
MDT icon

CAMG Solamere Management’s Medtronic MDT Stock Holding History

CAMG Solamere Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,960
Closed -$230K – 91
2020
Q4 		$230K Sell
1,960
-14,955
-88% -$1.65M 0.19% 87
2020
Q3 		$1.76M Sell
16,915
-10,197
-38% -$1.02M 0.98% 35
2020
Q2 		$2.49M Sell
27,112
-10,975
-29% -$1.05M 1.37% 14
2020
Q1 		$3.43M Buy
+38,087
New +$4.05M 1.8% 13

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAMG Solamere Management's MDT Position: Q1 2021 in Review

CAMG Solamere Management sold out of Medtronic (MDT) in Q1 2021, closing a stake of 1,960 shares — an estimated $230K sold.

CAMG Solamere Management first reported a position in MDT in Q1 2020 and held it in 4 quarters. The position peaked at $3.43M in Q1 2020. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • CAMG Solamere Management reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
  • CAMG Solamere Management sold 1,960 Medtronic shares in Q1 2021, an estimated $230K.
  • CAMG Solamere Management first reported a position in Medtronic in Q1 2020 and held it in 4 quarters.
  • CAMG Solamere Management's Medtronic position peaked at $3.43M in Q1 2020.
  • 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on CAMG Solamere Management's 13F filing for Q1 2021, filed 17 May 2021.